Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Beren, Cogent, Corcept, Enterome, Gene Solutions, Innocare, Ironwood, Renovorx, Sanofi, Solu, Zenas.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Atmo, Bridgebio, Cardiosense, Corcept, Dizal, Innocare, Nuvalent, Precigen, Senzime, Subtle, Vanda.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Autobahn, Cornerstone, Dyne, Gilead, H. Lundbeck, Microbot, Outlook, Pfizer, Pharming, Spectral, Toby.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Agios, Astellas, Astrazeneca, Boehringer, Daiichi, Gilead, Merck, Novo, Regeneron, Teva.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Boehringer Ingelheim, Daiichi Sankyo, GSK, H. Lundbeck, Hutchmed, Innovent, Junshi, Lupin, Maat, Mabwell.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adagio, Bayer, Hutchmed, Innovent, Junshi, Leo Cancer, Maat, Mabwell.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Diasorin, Guardant, Immunitybio, Implantica.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Bayer, Belite Bio, Cullinan, Intrabio, Lupin, Galvanize, Portal Access, Sunrise.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Accord Biopharma, Acist, Astrazeneca, Boehringer Ingelheim, Daiichi, Genentech, GSK, H. Lundbeck, Krystal, Natera, Vertanical, Viatris.

Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Fujirebio, Gyre, H.U. Group, Innovent, Kyowa Kirin, Shionogi, Taiho, Taiho Oncology, Viiv Healthcare, Zai Lab, Zhejiang Wenda.